Clear cell renal cell carcinoma (ccRCC), the most common subtype of human kidney carcinomas, is commonly associated with the inactivating mutations of VHL leading to a loss of function of the von Hippel‐Lindau tumour suppressor protein (pVHL). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.